A carregar...
Shifting Focus in the Therapeutics of Immunobullous Disease
Therapeutics of autoimmune bullous disease has seen a major shift of focus from more global immunosuppression to targeted immunotherapy. Anti CD 20 monoclonal antibody Rituximab revolutionized the therapeutics of autoimmune bullous disease particularly pemphigus. Though it is still being practiced o...
Na minha lista:
| Publicado no: | Indian J Dermatol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5448263/ https://ncbi.nlm.nih.gov/pubmed/28584371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijd.IJD_199_17 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|